Intramuscular Neural Distribution of Rhomboid Muscles: Evaluation for Botulinum Toxin Injection Using Modified Sihler's Method by 김희진 et al.
toxins
Article
Intramuscular Neural Distribution of Rhomboid
Muscles: Evaluation for Botulinum Toxin Injection
Using Modified Sihler’s Method
Kyu-Ho Yi 1, Hyung-Jin Lee 2, You-Jin Choi 2, Ji-Hyun Lee 2 , Kyung-Seok Hu 2
and Hee-Jin Kim 2,3,*
1 Inje County Public Health Center, Inje 24633, Korea; kyuho90@daum.net
2 Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification
Research Institute, BK21 PLUS Project, Yonsei University College of Dentistry, 50-1 Yonsei-ro,
Seodaemun-gu, Seoul 03722, Korea; leehj221@yuhs.ac (H.-J.L.); cyj7797@yuhs.ac (Y.-J.C.);
jh_anatomy@naver.com (J.-H.L.); hks318@yuhs.ac (K.-S.H.)
3 Department of Materials Science & Engineering, College of Engineering, Yonsei University,
Seoul 03722, Korea
* Correspondence: hjk776@yuhs.ac
Received: 28 February 2020; Accepted: 30 April 2020; Published: 3 May 2020


Abstract: This study describes the nerve entry point and intramuscular nerve branching of the
rhomboid major and minor, providing essential information for improved performance of botulinum
toxin injections and electromyography. A modified Sihler method was performed on the rhomboid
major and minor muscles (10 specimens each). The nerve entry point and intramuscular arborization
areas were identified in terms of the spinous processes and medial and lateral angles of the scapula.
The nerve entry point for both the rhomboid major and minor was found in the middle muscular
area between levels C7 and T1. The intramuscular neural distribution for the rhomboid minor
had the largest arborization patterns in the medial and lateral sections between levels C7 and T1.
The rhomboid major muscle had the largest arborization area in the middle section between levels T1
and T5. In conclusion, botulinum neurotoxin injection and electromyography should be administered
in the medial and lateral sections of C7−T1 for the rhomboid minor and the middle section of T1−T7
for the rhomboid major. Injections in the middle section of C7−T1 should also be avoided to prevent
mechanical injury to the nerve trunk. Clinicians can administer safe and effective treatments with
botulinum toxin injections and other types of injections by following the methods in our study.
Keywords: botulinum toxin; injection; clinical guideline; rhomboid muscle; spasticity
Key Contribution: The study provides a guide for effective botulinum toxin injection for
rhomboid muscles.
1. Introduction
Spasticity is a major contributor to movement disorders involving central nervous system
impairment, such as stroke and brain injury [1]. Patients with hemiplegic neurologic impairment
frequently suffer from shoulder spasticity, which limits shoulder movement and causes shoulder
pain [2–5]. The rhomboid major and minor muscles are the core muscles targeted for treatment in
patients with shoulder spasticity [4]. Involuntary activations of spastic rhomboid muscles cause the
scapula to be in an elevated and medially rotated position [6]. The reduction of involuntary activations
in spastic rhomboid muscles may result in proper positioning of the scapula with coordinated movement
of the glenohumeral joint. Botulinum toxin (BoNT) is considered a leading therapy for the reduction of
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shoulder spasticity [5,7,8]. The intramuscular injection of BoNT interferes with neural transmission
by decreasing the release of acetylcholine at the neuromuscular junction and deactivates muscle
contraction [9].
Currently, BoNT injections are known to be among the safest and most effective methods for
alleviating spasticity [10–13]. The amount of BoNT should be sufficient to allow toxin levels into the
arborized area of neural distribution. The effect of the BoNT depends on uptake by the presynaptic
membrane of the motor neuron at the neuromuscular junction; therefore, the injection should be given
into the neuromuscular junction area [14–16]. The significance of using neuromuscular-junction-targeted
BoNT injections has been confirmed in a clinical study on biceps brachii muscle and iliopsoas muscle.
The neuromuscular-junction-targeted injection resulted in much greater volume reduction than those
seen in the control groups [17,18].
However, a high dose of BoNT can cause the toxin to disperse to nearby muscles and
cause undesirable paralysis [19,20]. Furthermore, frequent and excessively high doses of BoNT
in injections lead to the production of antibodies that decrease the effect of treatment [19–21]. Therefore,
to minimize the side effects and maximize the efficacy, the BoNT should be injected into the arborized
zones. Many studies on the anatomical locations of arborized areas of targeted muscles have been
published [22–25]. A previous study reported dorsal scapular neuropathy after injective treatment on
the rhomboid muscle [26]. This was caused by an injection targeted at the entry point of the muscle,
not at the arborized zones.
However, to date, no studies have revealed the intramuscular nerve distributions and arborized
areas of the rhomboid muscles. In this study, we used the modified Sihler staining technique, which is
a whole-mount staining technique that effectively displays intramuscular nerve distributions without
damaging nerves.
The aims of this study were to elucidate the intramuscular nerve branching patterns and determine
the arborized areas of the rhomboid muscles using Sihler staining. The results of this study allow the
identification of effective and safe injection points for BoNT in patients with shoulder spasticity.
2. Results
2.1. Locations of the Nerve Entry Points
From the sample of dissected specimens, 28 of the 30 had a dorsal scapular nerve entry point in
the middle section of C7−T1, and 2 of the 30 specimens had a dorsal scapular nerve entry point in the
middle section of T1−T2.
2.2. Intramuscular Arborization Patterns of the Rhomboid Minor
According to the dissection and modified Sihler staining method, 18 of the 30 rhomboid minor
muscles had two regions in which the arborization patterns were the largest: the medial section of
C7− T1 and the lateral section of C7−T1. Additionally, 10 had the largest arborization patterns in the
medial section of C7−T1 and middle section of C7−T1. The remaining two specimens appeared to
have the largest arborization patterns in the middle and lateral section of C7 to T1. A schematic image
of an intramuscular arborization pattern is shown in Figure 1.
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Figure 1. Schematic view of the right side of the rhomboid muscle and intramuscular nerve 
distribution. (C7: spinous process of C7, T5: spinous process of T5, MA: medial angle, IA: inferior 
angle, M: medial, L: lateral, CR: cranial, CA: caudal). 
2.3. Intramuscular Arborization Patterns of the Rhomboid Major 
The dissection and modified Sihler staining method demonstrated that a total of 26 of the 30 
rhomboid major muscles had four sections in which the arborization patterns were the largest, in the 
middle section of T1−T5; three muscles had the largest arborization patterns in the middle section of 
T1−T3 and lateral section of T3−T5; one had the largest arborization patterns in the middle section of 
T1−T3 and medial section of T3−T5. 
3. Discussion 
Rhomboid muscles act as scapular rotators and retractors. The muscles are located beneath the 
middle trapezius. The dorsal scapular nerve, which originates from spinal nerve root C5, innervates 
the rhomboid muscles. The rhomboid muscles can be divided into the rhomboid minor and major 
muscles. The rhomboid minor originates from the spinous process of C7–T1 and inserts on the medial 
angle of the scapula. The rhomboid major muscle originates from the spinous processes of the 
vertebrae T2 to T5 and inserts on the medial border of the scapula [27]. 
Previous studies have shown the extramuscular running pattern of the dorsal scapular nerve 
but not intramuscular nerve innervation, which is important for treatments and diagnostic tools 
involving injections and electromyography [28]. 
There are studies that showed that periscapular muscles with focal spasticity could be managed 
with BoNT injections. In these clinical studies, BoNT injections were guided by electromyography 
and focal tenderness, not by intramuscular neural innervations. However, these treatments did show 
improvement in the limited range of motion and a reduction in shoulder pain [6]. 
The nerve entry point is where the nerve enters the muscle. The nerve entry point is targeted for 
the treatment of myofascial pain syndrome, involving injections of local anesthetics [29–31]. These 
treatments are known to relieve pain. However, no research regarding the rhomboid muscles as 
nerve entry points has been conducted. 
The rhomboid muscles play an important role in needle electromyography, as they are one of 
the few muscles with C5 innervation only [32]. Needle EMG is a tool used for evaluating 
neuromuscular disorders, whereby a needle electrode is inserted into the targeted muscle [33]. 
Figure 1. Schematic view of the right side of the rhomboid muscle and intramuscular nerve distribution.
(C7: spinous process of C7, T5: spinous process of T5, MA: medial angle, IA: inferior angle, M: medial,
L: lateral, CR: cranial, CA: caudal).
2.3. Intramuscular Arborization Patterns of the Rhomboid Major
The dissection and modified Sihler staining method demonstrated that a total of 26 of the
30 rhomboid major muscles had four sections in which the arborization patterns were the largest, in the
middle section of T1−T5; three muscles had the largest arborization patterns in the middle section of
T1−T3 and lateral section of T3−T5; one had the largest arborization patterns in the middle section of
T1−T3 and medial section of T3−T5.
3. Discussion
Rhomboid muscles act as scapular rotators and retractors. The muscles are located beneath the
middle trapezius. The dorsal scapular nerve, which originates from spinal nerve root C5, innervates the
rhomboid muscles. The rhomboid muscles can be divided into the rhomboid minor and major muscles.
The rhomboid minor originates from the spinous process of C7–T1 and inserts on the medial angle of
the scapula. The rhomboid major muscle originates from the spinous processes of the vertebrae T2 to
T5 and inserts on the medial border of the scapula [27].
Previous studies have shown the extramuscular running pattern of the dorsal scapular nerve but
not intramuscular nerve innervation, which is important for treatments and diagnostic tools involving
injections and electromyography [28].
There are studies that showed that periscapular muscles with focal spasticity could be managed
with BoNT injections. In these clinical studies, BoNT injections were guided by electromyography
and focal tenderness, not by intramuscular neural innervations. However, these treatments did show
improvement in the limited range of motion and a reduction in shoulder pain [6].
The nerve entry point is where the nerve enters the muscle. The nerve entry point is targeted
for the treatment of myofascial pain syndrome, involving injections of local anesthetics [29–31].
These treatments are known to relieve pain. However, no research regarding the rhomboid muscles as
nerve entry points has been conducted.
The rhomboid muscles play an important role in needle electromyography, as they are one of the
few muscles with C5 innervation only [32]. Needle EMG is a tool used for evaluating neuromuscular
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disorders, whereby a needle electrode is inserted into the targeted muscle [33]. Scapular winging
may occur when the dorsal scapular nerve is damaged. Many studies have reported this occurrence,
especially in sport players with repetitive stretching and forceful shoulder movement damage to the
dorsal scapular nerve [28,33,34]. Dorsal scapular nerve damage is diagnosed by electromyography.
Therefore, the intramuscular neural distribution that we provided can be used to guide the practice of
needle electromyography.
Injections of BoNT are used not only for spasticity but also for atypical post-traumatic
dystonia [35–37]. The study by Lee et al. targeted the rhomboid muscles with BoNT, and it was shown
to be successful in lowering the frequency of dystonic movements [36]. Aldo et al. reported that
botulinum toxin showed a significant decrease in pain and, to a lesser extent, dystonic movement in
patients [35].
Injection techniques targeting the rhomboid muscles have been shown to be associated with
many side effects. Lee et al. reported a patient who developed right dorsal scapular neuropathy
after trigger point injection which directly damaged nerve trunk on the right rhomboid muscle [26].
They have urged clinicians to exercise caution when injecting near the medial border of the scapula.
However, our findings indicate that the middle section between C7 and T1 should be avoided in order
to prevent neuropathy.
Nerve damage can occasionally occur following injectable treatments targeting the muscle,
due to direct needle traumas, such as EMG, trigger point injection, and BoNT injection [38–40].
In order to avoid any damage to the nerve, it is necessary that clinicians have knowledge of the exact
neural distribution.
Furthermore, for regional anesthesia, rhomboid intercostal blocks targeting the T3−T9 levels
are mainly performed by penetrating the rhomboid muscle, which may damage the dorsal
scapular nerve [41,42]. Here, we suggest avoiding the middle section of the rhomboid muscles
for these procedures.
Previous studies administered amounts of BoNT injection to the rhomboid muscle ranging from
10 to 50 units with one to three injection sites [6,43]. Seol et al. reported that the thickness of the
rhomboid major muscle is 9–10 mm [44]. BoNT usually spreads up to 2–4 cm from the injection site [16].
The research regarding diffusion of BoNT has recommended multiple injections to prevent spread
beyond the targeted muscle.
4. Conclusions
In conclusion, we recommend that clinicians perform injections at multiple sites (six or more)
with a low dose of BoNT (each 10 units) for maximum effect and to avoid side effects. We also suggest
that BoNT injections and electromyography are administered in the medial and lateral sections of
C7−T1 for the rhomboid minor and the middle section of T1−T7 for the rhomboid major (Figure 2).
In the case of BoNT injections, the nerve entry point of the middle section of C7−T1 should be avoided
to prevent damage to the nerve trunk. Clinicians can increase the effectiveness of BoNT injections and
other treatments and diagnostic methods by following the methods in this study.
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Figure 2. Guidelines for selective botulinum toxin A injection in the rhomboid muscles. The arborized 
portion of the rhomboid minor muscle was located in the medial and lateral section of C7−T1, and 
that of the rhomboid major was located in the middle section of T1−T5. The figure represents the right 
side of the rhomboid specimen. 
5. Materials and Methods 
This study was performed in accordance with the principles outlined in the Declaration of 
Helsinki. Appropriate consent and approval were obtained from the families of the cadavers before 
the dissections were performed. A total of 30 rhomboid major and 30 minor muscles from Korean 
cadavers (12 men and 3 women with a mean age of 73.2 years; range, 60–96 years) were dissected, 
and 10 of each were subjected to modified Sihler staining to elucidate the intramuscular nerve 
arborization patterns. 
Prior to dissection, the rhomboid major and minor muscles were aligned in their anatomical 
positions. The arborizing patterns of the muscles were traced according to four landmarks: the medial 
and inferior angles of the scapula and spinous processes of C7 and T5 (Figure 3). Then, we carefully 
recorded the nerve entry point where the nerves pierce into the muscle belly. The intramuscular 
neural distribution was traced with microscopic dissection before the staining procedure. 
Figure 2. Guidelines for selective botulinum toxin A injection in the rhomboid muscles. The arborized
portion of the rhomboid minor muscle was located in the medial and lateral section of C7− 1, nd that
of the rhomboid major was located in the middle section of T1−T5. The figure epr sents the right side
of the rhomboid specimen.
5. Materials and Methods
This study was performed in accordance with the principles outlined in the Declaration of
Helsinki. Appropriate consent and approval were obtained from the families of the cadavers before the
dissections were performed. A total of 30 rhomboid major and 30 minor muscles from Korean cadavers
(12 men and 3 women with a ean age of 73.2 years; range, 60–96 years) were dissected, and 10 of each
were subjected to modified Sihler staining to elucidate the intramuscular nerve arborization patterns.
Prior to dissection, the rhomboid major and minor muscles were aligned in their anatomical
positions. The arborizing patterns of the muscles were traced according to four landmarks: the medial
and inferior angles of the scapula and spinous processes of C7 and T5 (Figure 3). Then, we carefully
recorded the nerve entry point where the nerves pierce into the muscle belly. The intra uscular neural
distribution was traced with microscopic dissection before the staining procedure.
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Figure 3. Specimens were harvested from the medial angle (MA) and inferior angle (IA) to the tips of 
the spinous processes of C7 and T5. The figure presents the left side of the rhomboid muscles. 
The rhomboid major and minor muscles underwent Sihler staining, as modified by Liem and 
Douwe van Willigen [25]. 
This method involves multiple steps to obtain a visual representation of the intramuscular nerve 
arborization pattern (Figure 4). 
Following Sihler staining, the rhomboid muscles were divided into five sections by an oblique 
line from the tips of the spinous processes (C7−T5) and three vertical lines (medial, middle, and 
lateral), which were equal in length. 
5.1. Modified Sihler Staining 
In the fixation stage, the harvested muscles underwent one month of fixation with 10% un-
neutralized formalin solution. The formalin solution was changed whenever it became opaque. 
In the maceration and depigmentation stage, the fixated specimens were washed in running 
water for 1 h. Then, they were placed in 3% aqueous potassium hydroxide mixed with hydrogen 
peroxide solution for four weeks. 
In the decalcification stage, the macerated specimens were placed in Sihler I solution, a 
compound of aqueous chloral hydrate, glycerin, and glacial acetic acid. 
In the staining stage, as soon as the specimens were decalcified, they were stained in Sihler II 
solution, a compound of aqueous chloral hydrate, glycerin, and acetic acid, for three to four weeks. 
In the destaining stage, the stained specimens were placed back in Sihler I solution to destain 
the muscle fibers. This procedure took 1 h. 
In the neutralization stage, the destained specimens were neutralized in running water for 35 
min and then immersed in a solution of 0.05% lithium carbonate for 1 h. 
Figure 3. Specimens were harvested from the medial angle (MA) and inferior angle (IA) to the tips of
the spinous processes of C7 and T5. The figure presents the left side of the rhomboid muscles.
The rhomboid major and minor muscles underwent Sihler staining, as modified by Liem and
Douwe van Willigen [25].
This method involves multiple steps to obtain a visual representation of the intramuscular nerve
arborization pattern (Figure 4).
Following S hler staining, the r omboid muscles were divided into five sections by an obli line
from the tips of the spinous processes (C7−T5) and three vertical lines (medial, middle, and lateral),
which were equal in length.
Modified Sihler Staining
In the fixation stage, the harvested muscles underwent one month of fixation with 10%
un-neutralized formalin solution. The formalin solution was changed whenever it became opaque.
In the maceration and depigmentation stage, the fixated specimens were washed in running water
for 1 h. Then, they were placed in 3% aqueous potassium hydroxide mixed with hydrogen peroxide
solution for four weeks.
In the decalcification tage, the mac rated specimens were placed in Sihler I solution, a compound
of aqueous chloral hydrate, glycerin, nd glacial acetic acid.
In the staining stage, as soon as the specimens were decalcified, they were stained in Sihler II
solution, a compound of aqueous chloral hydrate, glycerin, and acetic acid, for three to four weeks.
In the destaining stage, the stained specimens were placed back in Sihler I solution to destain the
muscle fibers. This procedure took 1 h.
In the neutralization stage, the destained specimens were neutralized in running water for 35 min
and then immersed in a solution of 0.05% lithium carbonate for 1 h.
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In the clearing stage, the neutralized specimens were cleared by increasing the concentrations of
glycerin over a period of four days. The concentration of glycerin was increased in 20% increments
to 100%.
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